Assembly of Artificial Oxidoreductases
人工氧化还原酶的组装
基本信息
- 批准号:BB/I014063/1
- 负责人:
- 金额:$ 37.56万
- 依托单位:
- 依托单位国家:英国
- 项目类别:Research Grant
- 财政年份:2011
- 资助国家:英国
- 起止时间:2011 至 无数据
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Proteins are biological molecules constructed from linear chains of amino acids that adopt complex 3D structures informed by their amino acid sequence. Each protein typically has a unique structure that is indelibly linked to the function it performs in nature. Enzymes are proteins that catalyze the chemical reactions that occur in the cell, examples of which facilitate the capture and storage of chemical energy from respiration and photosynthesis. The design of new artificial proteins and enzymes remains one of the great challenges in biochemistry, testing our fundamental understanding of the nature of protein as a material. Unlocking the exceptionally powerful array of chemistries that natural enzymes perform promises routes to new drugs, therapies and sources of renewable green energy. Most attempts to construct new enzymes have focussed on modifying natural proteins and enzymes to introduce new catalytic function with modest degrees of success. The problems associated with redesigning natural proteins are due to the layers of complexity that nature incorporates through natural selection into a protein's complicated 3D structure. This complexity serves to complicate functional deconstruction of naturally evolved proteins and enzymes, rendering their redesign intrinsically difficult. We believe that this complexity is not a necessary feature of proteins and enzymes. Our method to effectively avoid such complexity is to work with proteins that have been untouched by natural selection. These simple proteins, neoproteins, are small, robust protein scaffolds with generic amino acid sequences that serve as templates onto which natural protein functions can be added. Non-protein components of certain proteins and enzymes, such as the heme molecule of the protein hemoglobin, can be effectively supported in neoproteins and the various functions that these molecules perform in natural proteins can be exploited. An example of how this method can be effectively used is the creation of a heme-binding neoprotein capable of reversibly binding oxygen, a function common to myoglobin, hemoglobin and the recently discovered neuroglobin. Functional elements of engineering are added step-by-step and the requirements to form such a protein are surprisingly few in number. And, as E. coli produces the artificial protein in large quantities, the oxygen-binding neoprotein is exceptionally cheap to produce and easy to alter through standard molecular biology techniques. Since the oxygen bound state in heme proteins is a pre-requisite for a multitude of catalytic processes in natural proteins, we plan to take inspiration from nature to further the development of these proteins into artificial enzymes. We have developed the oxygen-binding neoprotein to include hemes rigidly attached to the protein backbone. This alleviates problems associated with heme loss from previous designs and allows for an unprecedented control of neoprotein properties and function. Since natural oxygen-dependent catalysis requires that oxygen be 'activated' by the controlled addition of electrons, we will explore this reaction in our oxygen binding neoproteins, gaining valuable information about the generation and stability of intermediates capable of powerful oxygenic catalysis. Ultimately, we plan to combine the oxygen binding and electron delivery functions into either a single protein or a combination of associated protein subunits with discrete functions. Much as modular furniture design uses combinations of smaller functionally independent subunits such as legs, drawers, shelves and assembles them to particular specifications, we think an analogous approach can be applied to the construction of new proteins and enzymes whose functions are dictated by the designer. An advantage of this approach is that through the reproduction of enzyme and protein function in artificial proteins a deep fundamental understanding of the workings of their natural counterparts is gained.
Proteins are biological molecules constructed from linear chains of amino acids that adopt complex 3D structures informed by their amino acid sequence. Each protein typically has a unique structure that is indelibly linked to the function it performs in nature. Enzymes are proteins that catalyze the chemical reactions that occur in the cell, examples of which facilitate the capture and storage of chemical energy from respiration and photosynthesis. The design of new artificial proteins and enzymes remains one of the great challenges in biochemistry, testing our fundamental understanding of the nature of protein as a material. Unlocking the exceptionally powerful array of chemistries that natural enzymes perform promises routes to new drugs, therapies and sources of renewable green energy. Most attempts to construct new enzymes have focussed on modifying natural proteins and enzymes to introduce new catalytic function with modest degrees of success. The problems associated with redesigning natural proteins are due to the layers of complexity that nature incorporates through natural selection into a protein's complicated 3D structure. This complexity serves to complicate functional deconstruction of naturally evolved proteins and enzymes, rendering their redesign intrinsically difficult. We believe that this complexity is not a necessary feature of proteins and enzymes. Our method to effectively avoid such complexity is to work with proteins that have been untouched by natural selection. These simple proteins, neoproteins, are small, robust protein scaffolds with generic amino acid sequences that serve as templates onto which natural protein functions can be added. Non-protein components of certain proteins and enzymes, such as the heme molecule of the protein hemoglobin, can be effectively supported in neoproteins and the various functions that these molecules perform in natural proteins can be exploited. An example of how this method can be effectively used is the creation of a heme-binding neoprotein capable of reversibly binding oxygen, a function common to myoglobin, hemoglobin and the recently discovered neuroglobin. Functional elements of engineering are added step-by-step and the requirements to form such a protein are surprisingly few in number. And, as E. coli produces the artificial protein in large quantities, the oxygen-binding neoprotein is exceptionally cheap to produce and easy to alter through standard molecular biology techniques. Since the oxygen bound state in heme proteins is a pre-requisite for a multitude of catalytic processes in natural proteins, we plan to take inspiration from nature to further the development of these proteins into artificial enzymes. We have developed the oxygen-binding neoprotein to include hemes rigidly attached to the protein backbone. This alleviates problems associated with heme loss from previous designs and allows for an unprecedented control of neoprotein properties and function. Since natural oxygen-dependent catalysis requires that oxygen be 'activated' by the controlled addition of electrons, we will explore this reaction in our oxygen binding neoproteins, gaining valuable information about the generation and stability of intermediates capable of powerful oxygenic catalysis. Ultimately, we plan to combine the oxygen binding and electron delivery functions into either a single protein or a combination of associated protein subunits with discrete functions. Much as modular furniture design uses combinations of smaller functionally independent subunits such as legs, drawers, shelves and assembles them to particular specifications, we think an analogous approach can be applied to the construction of new proteins and enzymes whose functions are dictated by the designer. An advantage of this approach is that through the reproduction of enzyme and protein function in artificial proteins a deep fundamental understanding of the workings of their natural counterparts is gained.
项目成果
期刊论文数量(10)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Arginine side chain interactions and the role of arginine as a gating charge carrier in voltage sensitive ion channels.
- DOI:10.1038/srep21759
- 发表时间:2016-02-22
- 期刊:
- 影响因子:4.6
- 作者:Armstrong CT;Mason PE;Anderson JL;Dempsey CE
- 通讯作者:Dempsey CE
Construction and in vivo assembly of a catalytically proficient and hyperthermostable de novo enzyme.
催化熟练且可超过的从头酶的结构和体内组装。
- DOI:10.1038/s41467-017-00541-4
- 发表时间:2017-08-25
- 期刊:
- 影响因子:16.6
- 作者:Watkins DW;Jenkins JMX;Grayson KJ;Wood N;Steventon JW;Le Vay KK;Goodwin MI;Mullen AS;Bailey HJ;Crump MP;MacMillan F;Mulholland AJ;Cameron G;Sessions RB;Mann S;Anderson JLR
- 通讯作者:Anderson JLR
A suite of de novo c-type cytochromes for functional oxidoreductase engineering.
一套用于功能性氧化还原酶工程的从头 C 型细胞色素。
- DOI:10.1016/j.bbabio.2015.11.003
- 发表时间:2016
- 期刊:
- 影响因子:0
- 作者:Watkins DW
- 通讯作者:Watkins DW
Constructing a man-made c-type cytochrome maquette in vivo: electron transfer, oxygen transport and conversion to a photoactive light harvesting maquette.
- DOI:10.1039/c3sc52019f
- 发表时间:2014-02-01
- 期刊:
- 影响因子:8.4
- 作者:Anderson JLR;Armstrong CT;Kodali G;Lichtenstein BR;Watkins DW;Mancini JA;Boyle AL;Farid TA;Crump MP;Moser CC;Dutton PL
- 通讯作者:Dutton PL
Expression and In Vivo Loading of De Novo Proteins with Tetrapyrrole Cofactors.
使用四吡咯辅因子表达和体内装载 De Novo 蛋白质。
- DOI:10.1007/978-1-0716-1826-4_8
- 发表时间:2022
- 期刊:
- 影响因子:0
- 作者:Curnow P
- 通讯作者:Curnow P
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Ross Anderson其他文献
Blackbox Attacks on Reinforcement Learning Agents Using Approximated Temporal Information
使用近似时间信息对强化学习代理进行黑盒攻击
- DOI:
- 发表时间:
2019 - 期刊:
- 影响因子:0
- 作者:
Yiren Zhao;Ilia Shumailov;Han Cui;Xitong Gao;R. Mullins;Ross Anderson - 通讯作者:
Ross Anderson
The Unlucky Voyage: Batavia’s (1629) Landscape of Survival on the Houtman Abrolhos Islands in Western Australia
不幸的航行:巴达维亚(1629)西澳大利亚霍特曼阿布罗霍斯群岛的生存景观
- DOI:
10.1007/s41636-023-00396-1 - 发表时间:
2023 - 期刊:
- 影响因子:0.8
- 作者:
A. Paterson;Jeremy Green;Wendy van Duivenvoorde;D. Franklin;Ambika Flavel;L. Smits;J. Shragge;M. Manders;C. Souter;D. Shefi;Ross Anderson;T. Hoskin;Nader Issa;Mike Nash - 通讯作者:
Mike Nash
Experimental investigation of methane hydrate growth and dissociation hysteresis in narrow pores
窄孔隙中甲烷水合物生长和解离滞后的实验研究
- DOI:
- 发表时间:
2004 - 期刊:
- 影响因子:0
- 作者:
Ross Anderson;M. Cueto;B. T. Kalorazi - 通讯作者:
B. T. Kalorazi
Hextend and 7.5% hypertonic saline with Dextran are equivalent to Lactated Ringer's in a swine model of initial resuscitation of uncontrolled hemorrhagic shock.
Heextend%20和%207.5%%20高渗%20盐水%20和%20葡聚糖%20是%20当量%20至%20乳酸%20林格氏%20in%20a%20猪%20模型%20of%20初始%20复苏%20of%20不受控制%20出血%20休克。
- DOI:
10.1097/ta.0b013e3182367b1c - 发表时间:
2011 - 期刊:
- 影响因子:0
- 作者:
G. Riha;Nicholas R. Kunio;Philbert Y. Van;Gregory J. Hamilton;Ross Anderson;J. Differding;M. Schreiber - 通讯作者:
M. Schreiber
A Wet Cold-Flow Technology for Tackling Offshore Flow-Assurance Problems
用于解决海上流量保证问题的湿冷流技术
- DOI:
- 发表时间:
2010 - 期刊:
- 影响因子:0
- 作者:
R. Azarinezhad;A. Chapoy;Ross Anderson;B. Tohidi - 通讯作者:
B. Tohidi
Ross Anderson的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Ross Anderson', 18)}}的其他基金
Creating and comprehending the circuitry of life: precise biomolecular design of multi-centre redox enzymes for a synthetic metabolism
创建和理解生命回路:用于合成代谢的多中心氧化还原酶的精确生物分子设计
- 批准号:
BB/W003449/1 - 财政年份:2022
- 资助金额:
$ 37.56万 - 项目类别:
Research Grant
Tracking Covid Cybercrime and Abuse
追踪 Covid 网络犯罪和滥用行为
- 批准号:
EP/V026178/1 - 财政年份:2020
- 资助金额:
$ 37.56万 - 项目类别:
Research Grant
Constructing catalytically proficient enzymes from de novo designed proteins
从头设计的蛋白质构建催化效率高的酶
- 批准号:
BB/R016445/1 - 财政年份:2018
- 资助金额:
$ 37.56万 - 项目类别:
Research Grant
Interdisciplinary Centre for Finding, Understanding and Countering Crime in the Cloud
寻找、理解和打击云端犯罪的跨学科中心
- 批准号:
EP/M020320/1 - 财政年份:2015
- 资助金额:
$ 37.56万 - 项目类别:
Research Grant
Building Solar-Powered, Carbon-Fixing Protoalgae
构建太阳能固碳原藻
- 批准号:
BB/M02315X/1 - 财政年份:2015
- 资助金额:
$ 37.56万 - 项目类别:
Research Grant
The Deterrence of Deception in Socio-Technical Systems
社会技术系统中欺骗的威慑
- 批准号:
EP/K033476/1 - 财政年份:2013
- 资助金额:
$ 37.56万 - 项目类别:
Research Grant
Measuring the Security of Internet Infrastructure
衡量互联网基础设施的安全性
- 批准号:
EP/H018298/1 - 财政年份:2010
- 资助金额:
$ 37.56万 - 项目类别:
Research Grant
相似海外基金
TRUST2 - Improving TRUST in artificial intelligence and machine learning for critical building management
TRUST2 - 提高关键建筑管理的人工智能和机器学习的信任度
- 批准号:
10093095 - 财政年份:2024
- 资助金额:
$ 37.56万 - 项目类别:
Collaborative R&D
QUANTUM-TOX - Revolutionizing Computational Toxicology with Electronic Structure Descriptors and Artificial Intelligence
QUANTUM-TOX - 利用电子结构描述符和人工智能彻底改变计算毒理学
- 批准号:
10106704 - 财政年份:2024
- 资助金额:
$ 37.56万 - 项目类别:
EU-Funded
Artificial intelligence in education: Democratising policy
教育中的人工智能:政策民主化
- 批准号:
DP240100602 - 财政年份:2024
- 资助金额:
$ 37.56万 - 项目类别:
Discovery Projects
Nanoengineered hybrid coatings that control inflammation to artificial bone
控制人造骨炎症的纳米工程混合涂层
- 批准号:
DP240103271 - 财政年份:2024
- 资助金额:
$ 37.56万 - 项目类别:
Discovery Projects
Lead-free Perovskite Nanowires for Artificial Photo-synapse Arrays
用于人工光突触阵列的无铅钙钛矿纳米线
- 批准号:
DE240100179 - 财政年份:2024
- 资助金额:
$ 37.56万 - 项目类别:
Discovery Early Career Researcher Award
Adaptive Artificial Receptors for Biomimetic Functions
仿生功能的自适应人工受体
- 批准号:
MR/X023303/1 - 财政年份:2024
- 资助金额:
$ 37.56万 - 项目类别:
Fellowship
Application of artificial intelligence to predict biologic systemic therapy clinical response, effectiveness and adverse events in psoriasis
应用人工智能预测生物系统治疗银屑病的临床反应、有效性和不良事件
- 批准号:
MR/Y009657/1 - 财政年份:2024
- 资助金额:
$ 37.56万 - 项目类别:
Fellowship
REU Site: CyberAI: Cybersecurity Solutions Leveraging Artificial Intelligence for Smart Systems
REU 网站:CyberAI:利用人工智能实现智能系统的网络安全解决方案
- 批准号:
2349104 - 财政年份:2024
- 资助金额:
$ 37.56万 - 项目类别:
Standard Grant
EAGER: Artificial Intelligence to Understand Engineering Cultural Norms
EAGER:人工智能理解工程文化规范
- 批准号:
2342384 - 财政年份:2024
- 资助金额:
$ 37.56万 - 项目类别:
Standard Grant
Reversible Computing and Reservoir Computing with Magnetic Skyrmions for Energy-Efficient Boolean Logic and Artificial Intelligence Hardware
用于节能布尔逻辑和人工智能硬件的磁斯格明子可逆计算和储层计算
- 批准号:
2343607 - 财政年份:2024
- 资助金额:
$ 37.56万 - 项目类别:
Standard Grant














{{item.name}}会员




